1. Brandt-Rauf PW, Pincus MR, Carney WP . The c-erb B-2 protein in oncogenesis: molecular structure to molecular epidemiology. Crit Rev Oncog 1994; 5: 313–329.
2. Ross JS, Fletcher JA . HER-2/neu (c-erb-B2) gene and protein in breast cancer. Am J Clin Pathol 1999; 112: S53–S67.
3. Mitchell MS, Press MF . The role of immunohistochemistry and fluorescence in situ hybridization for HER2/neu in assessing the prognosis of breast cancer. Semin Oncol 1999; 26: 108–116.
4. Harbeck N, Ross JS, Yurdseven S, Dettmar P, Polcher M, Kuhn W, et al. HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer. Int J Oncol 1999; 14: 663–671.
5. Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, et al. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol 1997; 15: 2894–2904.